A detailed history of Silverarc Capital Management, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 1,062,062 shares of KOD stock, worth $2.83 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
1,062,062
Previous 1,238,822 14.27%
Holding current value
$2.83 Million
Previous $6.52 Million 61.71%
% of portfolio
0.71%
Previous 2.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.48 $404,780 - $791,884
-176,760 Reduced 14.27%
1,062,062 $2.5 Million
Q1 2024

May 14, 2024

BUY
$3.01 - $7.45 $718,854 - $1.78 Million
238,822 Added 23.88%
1,238,822 $6.52 Million
Q4 2023

Feb 14, 2024

SELL
$1.4 - $3.24 $160,245 - $370,853
-114,461 Reduced 10.27%
1,000,000 $3.04 Million
Q3 2023

Nov 13, 2023

BUY
$1.8 - $7.49 $2.01 Million - $8.35 Million
1,114,461 New
1,114,461 $2.01 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $138M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.